BRIEF

on Aspire Biopharma, Inc. (NASDAQ:PWUP)

Aspire Biopharma Introduces BUZZ BOMB™, a Fast-Acting Pre-Workout Supplement

Stock price chart of Aspire Biopharma, Inc. (EBR:PWUP) showing fluctuations.

Aspire Biopharma Holdings, Inc. announced promising initial consumer feedback for BUZZ BOMB™, its sublingual pre-workout supplement. Leveraging over a decade of research, BUZZ BOMB™ uses sublingual nano technology to deliver caffeine quickly to the bloodstream, offering benefits to athletes and fitness enthusiasts.

BUZZ BOMB™ is being introduced in four flavors—Tropical Fruit, Mixed Berry, Peach Mango, and Mocha Coffee—and comes in single-serving packets for convenience. Aspire plans to officially launch the product at FITCON and Fit Expo in August, reaching a wide fitness audience.

CEO Michael Howe emphasized the potential market impact, citing the supplement's easy use and rapid effect. Aspire aims to expand its product line further in the nutraceutical and supplement market.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Aspire Biopharma, Inc. news